Skip to main content
SpringerLink
Log in

ICAM-1 and LFA-3 enhance the ability of anti-CD3 mAb to stimulate interferon γ production in interleukin-2-activated T cells

  • Original Articles
  • LAK, T Lymphocytes, ICAM-1, LFA-3, IFNγ
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Abstract

Interleukin-2 (IL-2)-activated killer cells, also referred to as lymphokine-activated killer (LAK) cells, are stimulated by tumor cells to express cytotoxic activity and to also secrete cytokines such as interferon γ (IFNγ) and tumor necrosis factor α (TNF α). We previously reported that secretion of cytokines by IL-2-activated T cells (LAK-T cells) is dependent on the initial cross-linking of the T cell receptor (TCR)-CD3-molecular complex, but the cross-linking of accessory molecules, such as LFA-1, CD2, CD44 and CD45, on LAK-T cells can enhance this cytokine production. We have developed an approach involving interspecific gene transfer to define further the contributions of LFA-1 and CD2 to the activation of LAK-T cells. The genes for huICAM-1 (a ligand for LFA-1) and huLFA-3 (a ligand for CD2) were transfected singly and in combination into a null mouse melanoma background, and clonal populations of cells that stably express ICAM-1 and/or LFA-3 were derived. Expression of the introduced ICAM-1 and/or LFA-3 by transfected cells enhanced their ability to bind LAK-T cells; the LFA-1/ICAM-1-mediated binding was not further enhanced by activation with phorbol 12-myristate 13-acetate. ICAM-1- and/or LFA-3-transfected cells, in the presence of immobilized anti-CD3, exhibited a greater ability to stimulate IFNγ secretion by LAK-T cells compared to the untransfected parental lines. This experimental system, which allows ICAM-1/LFA-1 and CD2/LFA-3 interactions to occur on the LAK-T cell at a site distal from the anti-CD3 signal, extends our understanding of LAK-T cell activation by establishing that both LFA-1/ICAM-1 and CD2/LFA-3 can mediate co-stimulation via adhesion and signaling events.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Alcover A, Alberini C, Acuto O, Clayton LK, Transy C, Spagnoli GC, et al (1988) Interdependence of CD3-Ti and CD2 activation pathways in human T lymphocytes. EMBO J 7:1973

    PubMed  Google Scholar 

  2. Carrera AC, Rincon M, Sanchez-Madrid F, Lopez-Botet M, Landazuri MO de (1988) Triggering of co-mitogenic signals in T cell proliferation by anti-LFA-1 (CD18, CD11a), LFA-3, and CD7 monoclonal antibodies. J Immunol 141:1919

    PubMed  Google Scholar 

  3. Chong AS-F, Hersh E, Grimes WJ (1988) Blocking of lymphokine activated killer (LAK) cell mediated cytotoxicity by cell-sized beads bearing tumor cell proteins. J Immunol 141:4418

    PubMed  Google Scholar 

  4. Chong AS-F, Scuderi P, Grimes WJ, Hersh EM (1989) Tumor targets stimulate IL-2 activated killer cells to produce interferon-γ and tumor necrosis factor. J Immunol 142:2133

    PubMed  Google Scholar 

  5. Chong AS-F, Ybarrondo B, Grimes WJ, Hersh EM, Scuderi P (1990) Phenotypic analyses of lymphokine-activated killer cells that release interferon and tumor necrosis factor. Cancer Immunol Immunother 31:255

    PubMed  Google Scholar 

  6. Chong AS-F, Boussy IA, Graf LH, Scuderi P (1992) Stimulation of IFN-γ, TNF-α and TNF-β secretion in IL-2-activated T cells: costimulatory roles for LFA-1, LFA-2, CD44 and CD45 molecules. Cell Immunol 144:69

    PubMed  Google Scholar 

  7. Chong AS-F, Staren ED, Scuderi P (1992) Monoclonal antibodies anti-CD3, anti-TCR-αβ and anti-CD2 act synergistically with tumor cells to stimulate lymphokine-activated killer cells and tumor-infiltrating lymphocytes to secrete interferon γ. Cancer Immunol Immunother 35:335

    PubMed  Google Scholar 

  8. Damle NK, Doyle LV, Bradley EC (1986) Interleukin 2-activated human killer cells are derived from phenotypically heterogenous precursors. J Immunol 137:2814

    PubMed  Google Scholar 

  9. Danielian S, Fagard R, Alcover A, Acuto O, Fischer S (1989) The lymphocyte-specific protein tyrosine kinase p56lck is hyperphosphorylated on serine and tyrosine residues within minutes after activation via T cell receptor or CD2. Eur J Immunol: 2183

  10. Denning SM, Dustin ML, Springer TA, Singer KH, Haynes BF (1988) Purified lymphocyte function-associated antigen-3 (LFA-3) activates human thymocytes via the CD2 pathway. J Immunol 141:2980

    PubMed  Google Scholar 

  11. Dustin ML, Springer TA (1989) T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1. Nature 341:619

    PubMed  Google Scholar 

  12. Dustin ML, Selvaraj P, Mattaliano RJ, Springer TA (1987) Anchoring mechanisms for LFA-3 cell adhesion glycoprotein at membrane surface. Nature 329:846

    PubMed  Google Scholar 

  13. Ferrini S, Miescher S, Zocchi MR, Fliedner V van, Moretta A (1987) Phenotypic and functional characterization of recombinant interleukin 2 (IL-2)-induced activated killer cells: Analysis at the population and clonal levels. J Immunol 138:1297

    PubMed  Google Scholar 

  14. Graf LH, Kaplann P, Silagi S (1984) Efficient DNA-mediated transfer of selectable genes and unselected sequences into differentiated and undifferentiated mouse melanoma clones. Somatic Cell Mol Genetics 10:139

    Google Scholar 

  15. Graf LH, Rosenberg CD, Mancino V, Ferrone S (1988) Transfer and coamplification of a gene encoding a 96 kDa immune IFN-inducible human melanoma-associated antigen: preferential expression by mouse melanoma host cells. J Immunol 141:1054

    PubMed  Google Scholar 

  16. Kerensky AM, Robbins E, Springer TA, Burakoff, SJ (1984) LFA-1, LFA-2 and LFA-3 antigens are involved in CTL-target conjugation. J Immunol 132:2180

    PubMed  Google Scholar 

  17. Kooyk Y van, Weil-van Kemenade P van de, Weder P, Kuijpers TW, Figdor CG (1989) Enhancement of LFA-1-mediated cell adhesion by triggering through CD2 or CD3 on T lymphocytes. Nature 342:811

    PubMed  Google Scholar 

  18. Kornberg LJ, Earp HS, Turner CE, Prockop C, Juliano RL (1991) Signal transduction by integrins: increased protein tyrosine phosphorylation caused by clustering of β1 integrins. Proc Natl Acad Sci USA 88:8392

    PubMed  Google Scholar 

  19. Kuhlman P, Moy VT, Lollo BA, Brian AA (1991) The accessory function of murine intercellular adhesion molecule-1 in T lymphocyte activation. Contributions of adhesion and co-activation. J Immunol 146:1773

    PubMed  Google Scholar 

  20. Lotze MT, Grimm EA, Mazumdar A, Strausser JL, Rosenberg SA (1981) Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor. Cancer Res 41:4420

    PubMed  Google Scholar 

  21. Makoba MW, Sanders ME, Luce GEG, Dustin ML, Springer TA, Clark EA, et al (1988) ICAM-1 a ligand for LFA-1-dependent adhesion of B, T and myeloid cells. Nature 331:86

    PubMed  Google Scholar 

  22. Marlin SD, Springer TA (1987) Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell 51:813

    PubMed  Google Scholar 

  23. Meuer SC, Hussey RE, Fabbi M, Fox D, Acuto O, Fitzgerald KA, et al (1984) An alternative pathway of T-cell activation: a functional role for the 50 kd T11 sheep erythrocyte receptor protein. Cell 36:897

    PubMed  Google Scholar 

  24. Moingeon PE, Lucich JL, Stebbins CC, Reeny MA, Koyasu S, Reinherz EL (1991) Complementary roles for CD2 and LFA-1 adhesion pathways during T cell activation. Eur J Immunol 21:605

    PubMed  Google Scholar 

  25. Pardi R, Bender JR, Dettori C, Giannazza E, Engleman EG (1989) Heterogeneous distribution and transmembrane signalling properties of lymphocyte function-associated antigen (LFA-1) in human lymphocyte subsets. J Immunol 143:3157

    PubMed  Google Scholar 

  26. Seed B (1987) An LFA-3 cDNA encodes a phospholipid-linked membrane protein homologous to its receptor CD2. Nature 329:840

    PubMed  Google Scholar 

  27. Seventer GA van, Shimizu Y, Horgan KJ, Shaw S (1990) The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. J Immunol 144:4579

    PubMed  Google Scholar 

  28. Seventer GA van, Newman W, Shimizu Y, Nutman TB, Tanaka Y, Horgan KJ, et al (1991) Analysis of T cell stimulation by superantigen plus major histocompatibility complex class II molecules or by CD3 monoclonal aantibody: costimulation by purified adhesion ligands VCAM-1, ICAM-1, but not ELAM-1. J Exp Med 174:901

    PubMed  Google Scholar 

  29. Seventer GA van, Shimizu Y, Horgan KJ, Luce GEG, Webb D, Shaw S (1991) Remote T cell co-stimulation via LFA-1/ICAM-1 and CD-2/LFA-3: demonstration with immobilized ligand/mAb and implication in monocyte-mediated co-stimulation. Eur J Immunol 21:1711

    PubMed  Google Scholar 

  30. Shimizu Y, Seventer G van, Horgan KJ, Shaw S (1990) Regulated expression and binding of three VLA (β1) integrin receptors on T cells. Nature 345:250

    PubMed  Google Scholar 

  31. Springer TA (1990) Adhesion receptors of the immune system. Nature 346:425

    PubMed  Google Scholar 

  32. Wacholtz MC, Patel SS, Lipsky PE (1989) Leukocyte function-associated antigen 1 is an activation molecule for human T cells. J Exp Med 170:431

    PubMed  Google Scholar 

  33. Yamada A, Kaneyuki T, Torimoto Y, Daley JF, Prado CM, Yokoyama MM (1992) Signalling from LFA-1 contributes signal transduction through CD2 alternative pathway in T cell activation. Cell Immunol 142:145

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of General Surgery and Immunology/Microbiology, Rush Presbyterian-St. Lukes Medical Center, 1653 W. Congress Parkway, 60612, Chicago, IL, USA

    Anita S. -F. Chong & XingLi Jiang

  2. Institute for Inflammation and Experimental Medicine, Miles Research Institute, W. Haven, CT, USA

    Philip Scuderi

  3. Center for Research in Molecular Biology of Oral Diseases and Department of Physiology, University of Illinois, Chicago, IL, USA

    Marlene Lamas & Lloyd H. Graf Jr.

Authors
  1. Anita S. -F. Chong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. XingLi Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Philip Scuderi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marlene Lamas
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Lloyd H. Graf Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chong, A.S.F., Jiang, X., Scuderi, P. et al. ICAM-1 and LFA-3 enhance the ability of anti-CD3 mAb to stimulate interferon γ production in interleukin-2-activated T cells. Cancer Immunol Immunother 39, 127–134 (1994). https://doi.org/10.1007/BF01525318

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01525318

Key words

Search

Navigation